Alpha-9 Oncology
BiotechnologyWebsite
Operator of a radiopharmaceutical company intended to improve the diagnosis and treatment of metastatic cancer. The company develops imaging and therapeutic molecules for solid and hematologic maligna...
Valuation
$0
Share Price
N/A
Total Raised
$261.1M
Last Round
Later Stage VC (Series C)
Oct 2024
Latest Funding Round
Later Stage VC (Series C)
Oct 23, 2024
$175M
raised
Investors
+17 other investors